` SRNE (Sorrento Therapeutics Inc) vs S&P 500 Comparison - Alpha Spread

SRNE
vs
S&P 500

Over the past 12 months, SRNE has significantly outperformed S&P 500, delivering a return of +125% compared to the S&P 500's +14% growth.

Stocks Performance
SRNE vs S&P 500

Loading
SRNE
S&P 500
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
SRNE vs S&P 500

Loading
SRNE
S&P 500
Difference
www.alphaspread.com

Performance By Year
SRNE vs S&P 500

Loading
SRNE
S&P 500
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Sorrento Therapeutics Inc vs Peers

S&P 500
SRNE
ABBV
AMGN
GILD
VRTX
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Sorrento Therapeutics Inc
Glance View

Market Cap
978.7k USD
Industry
Biotechnology

Sorrento Therapeutics, Inc. engages in the research, development and manufacture of biopharmaceutical products. The company is headquartered in San Diego, California and currently employs 799 full-time employees. The company went IPO on 2007-01-19. The firm's segments include Sorrento Therapeutics and Scilex. The Sorrento Therapeutics segment is organized around Immune-Oncology therapeutic area, leveraging its G-MAB antibody library and targeted delivery modalities to generate cancer therapeutics. The Scilex segment is largely organized around its non-opioid pain management operations. Sorrento's immuno-oncology platforms include key assets such as fully human antibodies (G-MAB library), immuno-cellular therapies (DAR-T), antibody-drug conjugates (ADCs), and oncolytic virus (Seprehvec). Sorrento is also developing antiviral therapies and vaccines against coronaviruses, including Abivertinib, COVI-AMG, COVISHIELD, COVI-MSC and COVIDROPS; and diagnostic test solutions, including COVITRACK and COVISTIX.

SRNE Intrinsic Value
Not Available
Back to Top